Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Clove Basil Leaf (Ocimum gratissimum) contains 40-80% eugenol in its essential oil, which inhibits COX enzymes and downregulates inflammatory cytokines IL-6 and TNF-α. The leaf also provides thymol for antimicrobial activity and β-caryophyllene for CB2 receptor-mediated inflammation control.
Reported Benefits (Provisional)
Origin & History
Clove Basil Leaf (Ocimum gratissimum) is an aromatic herb native to tropical and subtropical regions of West Africa, India, and Southeast Asia. Thriving in well-drained soils under full sun, this botanical is highly valued in traditional medicine for its diverse therapeutic properties, particularly for respiratory, immune, and nervous system support.
Research Narrative (Provisional)
Research published in NCBI and ScienceDirect indicates Clove Basil's significant anti-inflammatory, antimicrobial, and anxiolytic properties, primarily attributed to its eugenol content. Studies support its traditional uses for respiratory and immune health, though more human clinical trials are warranted.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Bioactives: Eugenol (primary compound), Linalool, Rosmarinic Acid, Flavonoids, Tannins, Essential Oils
Reported Mechanism (Provisional)
Eugenol inhibits cyclooxygenase enzymes and suppresses NF-κB and MAPK inflammatory pathways while downregulating cytokines IL-6 and TNF-α. Thymol disrupts bacterial cell membranes against E. coli and Staphylococcus aureus, while β-caryophyllene modulates inflammation via CB2 cannabinoid receptors. Flavonoids like luteolin and apigenin provide antioxidant protection through free radical scavenging and metal chelation.
Clinical Narrative (Provisional)
In vitro studies show leaf extracts at 400-800 μg/mL reduced hepatocellular carcinoma cell viability and decreased inflammatory markers. Rat studies using 50-100 mg/kg phenolic-enriched fractions demonstrated reduced carrageenan-induced inflammation with lower TNF-α levels and myeloperoxidase activity. Aqueous extracts at 20-80 mg/mL protected HepG2 cells from oxidative damage in laboratory conditions. Evidence remains limited to animal and cell culture studies with no large-scale human clinical trials available.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.